8-70128448-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_006540.4(NCOA2):āc.3666T>Cā(p.Pro1222=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00219 in 1,612,312 control chromosomes in the GnomAD database, including 83 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.012 ( 49 hom., cov: 32)
Exomes š: 0.0012 ( 34 hom. )
Consequence
NCOA2
NM_006540.4 synonymous
NM_006540.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.558
Genes affected
NCOA2 (HGNC:7669): (nuclear receptor coactivator 2) The protein encoded by this gene functions as a transcriptional coactivator for nuclear hormone receptors, including steroid, thyroid, retinoid, and vitamin D receptors. The encoded protein acts as an intermediary factor for the ligand-dependent activity of these nuclear receptors, which regulate their target genes upon binding of cognate response elements. This gene has been found to be involved in translocations that result in fusions with other genes in various cancers, including the lysine acetyltransferase 6A (KAT6A) gene in acute myeloid leukemia, the ETS variant 6 (ETV6) gene in acute lymphoblastic leukemia, and the hes related family bHLH transcription factor with YRPW motif 1 (HEY1) gene in mesenchymal chondrosarcoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 8-70128448-A-G is Benign according to our data. Variant chr8-70128448-A-G is described in ClinVar as [Benign]. Clinvar id is 783528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.558 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0119 (1815/152358) while in subpopulation AFR AF= 0.0416 (1730/41572). AF 95% confidence interval is 0.04. There are 49 homozygotes in gnomad4. There are 881 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1815 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCOA2 | NM_006540.4 | c.3666T>C | p.Pro1222= | synonymous_variant | 18/23 | ENST00000452400.7 | NP_006531.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCOA2 | ENST00000452400.7 | c.3666T>C | p.Pro1222= | synonymous_variant | 18/23 | 1 | NM_006540.4 | ENSP00000399968 | P1 | |
NCOA2 | ENST00000518363.2 | c.1044T>C | p.Pro348= | synonymous_variant | 6/11 | 2 | ENSP00000429132 | |||
NCOA2 | ENST00000521239.1 | n.109T>C | non_coding_transcript_exon_variant | 2/3 | 4 | |||||
NCOA2 | ENST00000518287.6 | c.*623T>C | 3_prime_UTR_variant, NMD_transcript_variant | 17/21 | 5 | ENSP00000430148 |
Frequencies
GnomAD3 genomes AF: 0.0119 AC: 1814AN: 152240Hom.: 49 Cov.: 32
GnomAD3 genomes
AF:
AC:
1814
AN:
152240
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00281 AC: 692AN: 246174Hom.: 14 AF XY: 0.00219 AC XY: 293AN XY: 133522
GnomAD3 exomes
AF:
AC:
692
AN:
246174
Hom.:
AF XY:
AC XY:
293
AN XY:
133522
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00118 AC: 1720AN: 1459954Hom.: 34 Cov.: 31 AF XY: 0.000990 AC XY: 719AN XY: 726088
GnomAD4 exome
AF:
AC:
1720
AN:
1459954
Hom.:
Cov.:
31
AF XY:
AC XY:
719
AN XY:
726088
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0119 AC: 1815AN: 152358Hom.: 49 Cov.: 32 AF XY: 0.0118 AC XY: 881AN XY: 74504
GnomAD4 genome
AF:
AC:
1815
AN:
152358
Hom.:
Cov.:
32
AF XY:
AC XY:
881
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 06, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at